4.8 Review

Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?

Journal

GUT
Volume 66, Issue 2, Pages 362-381

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2016-312673

Keywords

-

Funding

  1. MSD
  2. Actavis
  3. AbbVie
  4. Dr Falk Pharmaceuticals
  5. Shire

Ask authors/readers for more resources

The genetics of isolated colonic Crohn's disease place it approximately midway between Crohn's disease with small intestinal involvement and UC, making a case for considering it as a separate condition. We have therefore systematically reviewed its epidemiology, pathophysiology and treatment. Key findings include a higher incidence in females (65%) and older average age at presentation than Crohn's disease at other sites, a mucosa-associated microbiota between that found in ileal Crohn's disease and UC, no response to mesalazine, but possibly better response to antitumour necrosis factor than Crohn's disease at other sites. Diagnostic distinction from UC is often difficult and also needs to exclude other conditions including ischaemic colitis, segmental colitis associated with diverticular disease and tuberculosis. Future studies, particularly clinical trials, but also historical cohorts, should assess isolated colonic Crohn's disease separately.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available